- Liesa K. Hoppe1,2,
- Dana C. Muhlack1,2,
- Wolfgang Koenig3,4,5,
- Prudence R. Carr2,
- Hermann Brenner1,2 &
- …
- Ben Schöttker1,2,6
2305Accesses
7Altmetric
Abstract
Purpose
To provide the first systematic review and meta-analysis of observational studies on the association of abnormal serum potassium and cardiovascular outcomes.
Methods
Medline and ISI Web of Knowledge were systematically searched from inception until November 24, 2017. Data synthesis of relevant studies was performed using random effects model meta-analyses.
Results
Meta-analyses included 310,825 participants from 24 studies. In the older general population, low serum potassium was associated with a 1.6-fold increased risk of supraventricular arrhythmias (risk ratio [95% confidence interval] 1.62 [1.02–2.55]). Contrarily, high serum potassium was associated with increased cardiovascular mortality (CVM) (1.38 [1.14–1.66]). In patients with acute myocardial infarction, the risk of ventricular arrhythmias was increased for high serum potassium (2.33 [1.60–3.38]). A U-shaped association was observed with a composite cardiovascular outcome in hypertensive patients (2.6-fold increased risk with hypokalemia and 1.7-fold increased risk with hyperkalemia), with CVM in dialysis patients (1.1-fold increased risk with hypokalemia and 1.4-fold increased risk with hyperkalemia) and with CVM in heart failure patients (albeit not statistically significant). Further, only hyperkalemia was associated with an increased risk of a composite cardiovascular outcome in both dialysis (1.12 [1.03–1.23]) and chronic kidney disease (1.34 [1.06–1.71]) patients.
Conclusions
Controlled clinical trials are needed to determine which populations may profit from more frequent potassium-monitoring and subsequent interventions, e.g., change or withdrawal of potassium-influencing drugs, in order to restore normal values and prevent cardiovascular outcomes.
Registration Details
Registration in PROSPERO (Centre for Reviews and Dissemination University of York, York, UK): CRD42016048897 (https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=48897).
This is a preview of subscription content,log in via an institution to check access.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
Price includes VAT (Japan)
Instant access to the full article PDF.



Similar content being viewed by others
References
Cardiovascular diseases - fact sheet. World Health Organization.http://www.who.int/mediacentre/factsheets/fs317/en/. Accessed 21 Oct 2016
Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis. Adv Physiol Educ. 2016;40(4):480–90.
Lerma EV. Potassium. In: Drugs & disease - laboratory medicine.http://emedicine.medscape.com/article/2054364-overview. Accessed 23 Dec 2016
Brown MJ, Brown DC, Murphy MB. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983;309(23):1414–9.
Obeid AI, Verrier RL, Lown B. Influence of glucose, insulin, and potassium on vulnerability to ventricular fibrillation in the canine heart. Circ Res. 1978;43(4):601–8.
Kovesdy CP. Management of hyperkalaemia in chronic kidney disease. Nat Rev Nephrol. 2014;10(11):653–62.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.
Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 7 Dec 2016
Ahmed A, Zannad F, Love TE, Tallaj J, Gheorghiade M, Ekundayo OJ, et al. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J. 2007;28(11):1334–43.
Ahmed MI, Ekundayo OJ, Mujib M, Campbell RC, Sanders PW, Pitt B, et al. Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study. Int J Cardiol. 2010;144(3):383–8.
Aldahl M, Jensen AC, Davidsen L, Eriksen MA, Moller Hansen S, Nielsen BJ, et al. Associations of serum potassium levels with mortality in chronic heart failure patients. Eur Heart J. 2017;38(38):2890–6.
Brezins M, Elyassov S, Elimelech I, Roguin N. Comparison of patients with acute myocardial infarction with and without ventricular fibrillation. Am J Cardiol. 1996;78(8):948–50.
Bulpitt CJ, Bulpitt PF, Daymond M, Hartley K, Dollery CT. Fifteen year survival of patients presenting with hypertension to a hospital clinic. Postgrad Med J. 1986;62(727):335–40.
Chen Y, Chang AR, McAdams DeMarco MA, Inker LA, Matsushita K, Ballew SH, et al. Serum potassium, mortality, and kidney outcomes in the atherosclerosis risk in communities study. Mayo Clin Proc. 2016;91(10):1403–12.
Choi JS, Kim YA, Kim HY, Oak CY, Kang YU, Kim CS, et al. Relation of serum potassium level to long-term outcomes in patients with acute myocardial infarction. Am J Cardiol. 2014;113(8):1285–90.
Chow KM, Szeto CC, Kwan BC, Chung KY, Leung CB, Li PK. Factors associated with sudden death in peritoneal dialysis patients. Perit Dial Int J Int Soc Perit Dial. 2009;29(1):58–63.
Cleland JG, Dargie HJ, Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J. 1987;58(6):572–82.
Cohen HW, Madhavan S, Alderman MH. High and low serum potassium associated with cardiovascular events in diuretic-treated patients. J Hypertens. 2001;19(7):1315–23.
Dargie HJ, Cleland JG, Leckie BJ, Inglis CG, East BW, Ford I. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation. 1987;75(5 Pt 2):Iv98–107.
Davidson S, Surawicz B. Ectopic beats and atrioventricular conduction disturbances. In patients with hypopotassemia. Arch Intern Med. 1967;120(3):280–5.
D'Elia JA, Weinrauch LA, Gleason RE, Hampton LA, Smith-Ossman S, Yoburn DC, et al. Application of the ambulatory 24-hour electrocardiogram in the prediction of cardiac death in dialysis patients. Arch Intern Med. 1988;148(11):2381–5.
Detrano R, Maloney J, Leatherman J. Ventricular arrhythmias and serum potassium: is there a correlation in the arrhythmic patient? Cleve Clin Q. 1984;51(1):55–8.
Dyckner T, Helmers C, Wester PO. Initial serum potassium level, early arrhythmias and previous diuretic therapy in acute myocardial infarction. Int J Cardiol. 1982;2(1):146–8.
Fang J, Madhavan S, Cohen H, Alderman MH. Serum potassium and cardiovascular mortality. J Gen Intern Med. 2000;15(12):885–90.
Friedensohn A, Faibel HE, Bairey O, Goldbourt U, Schlesinger Z. Malignant arrhythmias in relation to values of serum potassium in patients with acute myocardial infarction. Int J Cardiol. 1991;32(3):331–8.
Genovesi S, Valsecchi MG, Rossi E, Pogliani D, Acquistapace I, De Cristofaro V, et al. Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc. 2009;24(8):2529–36.
Goyal A, Spertus JA, Gosch K, Venkitachalam L, Jones PG, Van den Berghe G, et al. Serum potassium levels and mortality in acute myocardial infarction. JAMA. 2012;307(2):157–64.
Gundling F, Schmidtler F, Zelihic E, Seidl H, Haller B, Ronel J, et al. Frequency of cardiac arrhythmia in patients with liver cirrhoses and evaluation of associated factors. Z Gastroenterol. 2012;50(11):1149–55.
Herlitz J, Hjalmarson A, Bengtson A. Occurrence of hypokalemia in suspected acute myocardial infarction and its relation to clinical history and clinical course. Clin Cardiol. 1988;11(10):678–82.
Higham PD, Adams PC, Murray A, Campbell RW. Plasma potassium, serum magnesium and ventricular fibrillation: a prospective study. Q J Med. 1993;86(9):609–17.
Huang CW, Lee MJ, Lee PT, Hsu CY, Huang WC, Chen CL, et al. Low potassium dialysate as a protective factor of sudden cardiac death in hemodialysis patients with hyperkalemia. PLoS One. 2015;10(10):e0139886.
Hughes-Austin JM, Rifkin DE, Beben T, Katz R, Sarnak MJ, Deo R, et al. The relation of serum potassium concentration with cardiovascular events and mortality in community-living individuals. Clin J Am Soc Nephrol CJASN. 2017;12(2):245–52.
Janko O, Seier J, Zazgornik J. Hypokalemia--incidence and severity in a general hospital. Wien Med Wochenschr (1946). 1992;142(4):78–81.
Kafka H, Langevin L, Armstrong PW. Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. Arch Intern Med. 1987;147(3):465–9.
Karaboyas A, Zee J, Brunelli SM, Usvyat LA, Weiner DE, Maddux FW, et al. Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the Dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis Off J Natl Kidney Found. 2017;69(2):266–77.
Keskin M, Kaya A, Tatlisu MA, Hayiroglu MI, Uzman O, Borklu EB, et al. The effect of serum potassium level on in-hospital and long-term mortality in ST elevation myocardial infarction. Int J Cardiol. 2016;221:505–10.
Korgaonkar S, Tilea A, Gillespie BW, Kiser M, Eisele G, Finkelstein F, et al. Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study. Clin J Am Soc Nephrol CJASN. 2010;5(5):762–9.
Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol. 2007;2(5):999–1007.
Krijthe BP, Heeringa J, Kors JA, Hofman A, Franco OH, Witteman JC, et al. Serum potassium levels and the risk of atrial fibrillation: the Rotterdam Study. Int J Cardiol. 2013;168(6):5411–5.
Lai YH, Leu HB, Yeh WT, Chang HY, Pan WH. Low-normal serum potassium is associated with an increased risk of cardiovascular and all-cause death in community-based elderly. J Formos Med Assoc Taiwan Yi Zhi. 2015;114(6):517–25.
Li SH, Xie JT, Long HB, Zhang J, Zhou WD, Niu HX, et al. Time-averaged serum potassium levels and its fluctuation associate with 5-year survival of peritoneal dialysis patients: two-center based study. Sci Rep. 2015;5:15743.
López Castro J, Ortega RA, Romero MPD, Juanatey JRG. Mortality prognosis factors in heart failure in a cohort of north-West Spain. EPICOUR study. Rev Clin Esp. 2010;210(9):438–47.
Luo J, Brunelli SM, Jensen DE, Yang A. Association between serum potassium and outcomes in patients with reduced kidney function. Clin J Am Soc Nephrol CJASN. 2016;11(1):90–100.
Madias JE, Shah B, Chintalapally G, Chalavarya G, Madias NE. Admission serum potassium in patients with acute myocardial infarction: its correlates and value as a determinant of in-hospital outcome. Chest. 2000;118(4):904–13.
Nielsen LK, Schultz A, Astrup G, Schmidt EB. Hypokalemia and arrhythmia in acute myocardial infarction. Ugeskr Laeger. 1986;148(16):951–3.
Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98(15):1510–6.
Nordrehaug JE, Johannessen KA, von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation. 1985;71(4):645–9.
Park S, Baek SH, Lee SW, Lee A, Chin HJ, Na KY, et al. Elevated baseline potassium level within reference range is associated with worse clinical outcomes in hospitalised patients. Sci Rep. 2017;7(1):2402.
Reuben SR, Thomas RD. The relationship between serum potassium and cardiac arrhythmias following cardiac infarction in patients aged over 65 years. Curr Med Res Opin. 1982;7(Suppl 1):79–82.
Ribeiro SC, Figueiredo AE, Barretti P, Pecoits-Filho R, de Moraes TP. Low serum potassium levels increase the infectious-caused mortality in peritoneal dialysis patients: a propensity-matched score study. PLoS One. 2015;10(6):e0127453.
Shlomai G, Berkovitch A, Pinchevski-Kadir S, Bornstein G, Leibowitz A, Goldenberg I, et al. The association between normal-range admission potassium levels in Israeli patients with acute coronary syndrome and early and late outcomes. Medicine. 2016;95(23):e3778.
Simpson RJ, Jr., Cascio WE, Schreiner PJ, Crow RS, Rautaharju PM, Heiss G. Prevalence of premature ventricular contractions in a population of African American and white men and women: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2002;143(3):535–540.
Su J, Fu X, Tian Y, Ma Y, Chen H, Wang Y, et al. Additional predictive value of serum potassium to thrombolysis in myocardial infarction risk score for early malignant ventricular arrhythmias in patients with acute myocardial infarction. Am J Emerg Med. 2012;30(7):1089–94.
Thomas RD. Ventricular fibrillation and initial plasma potassium in acute myocardial infarction. Postgrad Med J. 1983;59(692):354–6.
Torlen K, Kalantar-Zadeh K, Molnar MZ, Vashistha T, Mehrotra R. Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort. Clin J Am Soc Nephrol CJASN. 2012;7(8):1272–84.
Tsuji H, Venditti FJ Jr, Evans JC, Larson MG, Levy D. The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). Am J Cardiol. 1994;74(3):232–5.
Uluganyan M, Ekmekci A, Murat A, Avsar S, Ulutas TK, Uyarel H, et al. Admission serum potassium level is associated with in-hospital and long-term mortality in ST-elevation myocardial infarction. Anatolian J Cardiol. 2016;16(1):10–5.
Wagner S, Metzger M, Flamant M, Houillier P, Haymann JP, Vrtovsnik F, et al. Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care—the NephroTest study. BMC Nephrol. 2017;18(1):295.
Walsh CR, Larson MG, Leip EP, Vasan RS, Levy D. Serum potassium and risk of cardiovascular disease: the Framingham heart study. Arch Intern Med. 2002;162(9):1007–12.
Wannamethee SG, Lever AF, Shaper AG, Whincup PH. Serum potassium, cigarette smoking, and mortality in middle-aged men. Am J Epidemiol. 1997;145(7):598–606.
Xu Q, Xu F, Fan L, Xiong L, Li H, Cao S, et al. Serum potassium levels and its variability in incident peritoneal dialysis patients: associations with mortality. PLoS One. 2014;9(1):e86750.
Yusuf AA, Hu Y, Sing B, Menoyo JA, Wetmore JB. Serum potassium levels and mortality in hemodialysis patients: a retrospective cohort study. Am J Nephrol. 2016;44(3):179–86.
Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008;36(12):3246–51.
Dunn JD, Benton WW, Orozco-Torrentera E, Adamson RT. The burden of hyperkalemia in patients with cardiovascular and renal disease. Am J Manag Care. 2015;21(15 Suppl):s307–15.
Rossignol P, Legrand M, Kosiborod M, Hollenberg SM, Peacock WF, Emmett M, et al. Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future. Pharmacol Res. 2016;113(Pt A):585–91.
Koplan BA, Stevenson WG. Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc. 2009;84(3):289–97.
John RM, Tedrow UB, Koplan BA, Albert CM, Epstein LM, Sweeney MO, et al. Ventricular arrhythmias and sudden cardiac death. Lancet (London, England). 2012;380(9852):1520–9.
Gheeraert PJ, De Buyzere ML, Taeymans YM, Gillebert TC, Henriques JP, De Backer G, et al. Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis. Eur Heart J. 2006;27(21):2499–510.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol (English ed). 2016;69(12):1167.
Lehnhardt A, Kemper MJ. Pathogenesis, diagnosis and management of hyperkalemia. Pediatric Nephrol (Berlin, Germany). 2011;26(3):377–84.
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet (London, England). 2013;382(9889):339–52.
Karnik JA, Young BS, Lew NL, Herget M, Dubinsky C, Lazarus JM, et al. Cardiac arrest and sudden death in dialysis units. Kidney Int. 2001;60(1):350–7.
Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int. 2006;69(12):2268–73.
Al-Ghamdi G, Hemmelgarn B, Klarenbach S, Manns B, Wiebe N, Tonelli M. Dialysate potassium and risk of death in chronic hemodialysis patients. J Nephrol. 2010;23(1):33–40.
Pun PH, Lehrich RW, Honeycutt EF, Herzog CA, Middleton JP. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int. 2011;79(2):218–27.
Abuelo JG. Low dialysate potassium concentration: an overrated risk factor for cardiac arrhythmia? Semin Dial. 2015;28(3):266–75.
Hung AM, Hakim RM. Dialysate and serum potassium in hemodialysis. Am J Kidney Dise Off J Natl Kidney Found. 2015;66(1):125–32.
Karaboyas A, Zee J, Brunelli SM, Usvyat LA, Weiner DE, Maddux FW, et al. Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis Off J Natl Kidney Found. 2016;69:266–77.
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925–38.
How high blood pressure can lead to kidney damage or failure.http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/WhyBloodPressureMatters/How-High-Blood-Pressure-Can-Lead-to-Kidney-Damage-or-Failure_UCM_301825_Article.jsp#.WFz5Dn0TAhQ. Accessed 23 Dec 2016.
Cohn JN, Kowey PR, Whelton PK, Prisant LM. New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med. 2000;160(16):2429–36.
Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154–235.
Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol. 2004;43(2):155–61.
Van Harrison R, Lukela J, Jimbo M, Mahallati A, Saran R, Sy A. Management of chronic kidney disease. In: Guidelines for Clinical Care. 2014.
Collins AJ, Pitt B, Reaven N, Funk S, McGaughey K, Wilson D, et al. Association of Serum Potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes. Am J Nephrol. 2017;46(3):213–21.
Acknowledgements
We thank Maurizio Grilli for his advice and support concerning the development of the search strategy.
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Network Aging Research, University of Heidelberg, Heidelberg, Germany
Liesa K. Hoppe, Dana C. Muhlack, Hermann Brenner & Ben Schöttker
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Liesa K. Hoppe, Dana C. Muhlack, Prudence R. Carr, Hermann Brenner & Ben Schöttker
Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
Wolfgang Koenig
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Technische Universität München, Munich, Germany
Wolfgang Koenig
Department of Internal Medicine II – Cardiology, University of Ulm Medical Centre, Ulm, Germany
Wolfgang Koenig
Institute of Health Care and Social Sciences, FOM University, Essen, Germany
Ben Schöttker
- Liesa K. Hoppe
You can also search for this author inPubMed Google Scholar
- Dana C. Muhlack
You can also search for this author inPubMed Google Scholar
- Wolfgang Koenig
You can also search for this author inPubMed Google Scholar
- Prudence R. Carr
You can also search for this author inPubMed Google Scholar
- Hermann Brenner
You can also search for this author inPubMed Google Scholar
- Ben Schöttker
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toBen Schöttker.
Ethics declarations
Conflicts of Interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Online Resource 1
(PDF 477 kb)
Online Resource 2
(PDF 567 kb)
Online Resource 3
(PDF 477 kb)
Online Resource 4
(PDF 646 kb)
Online Resource 5
(PDF 505 kb)
Online Resource 6
(PDF 614 kb)
Online Resource 7
(PDF 500 kb)
Online Resource 8
(PDF 630 kb)
Rights and permissions
About this article
Cite this article
Hoppe, L.K., Muhlack, D.C., Koenig, W.et al. Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies.Cardiovasc Drugs Ther32, 197–212 (2018). https://doi.org/10.1007/s10557-018-6783-0
Published:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative